Clinical Trial Update: Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

Termination of a Phase 1/2 pediatric Crohn's disease trial sponsored by Genzyme; the update discusses the study's safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: TERMINATED